- On Track to Report Initial Clinical Data from pheEDIT PKU Gene Editing Trial Mid-Year 2023 - - First Presentations of Preclinical Data with GTx-mAb Development Candidate HMI-104 for PNH, and. | May 11, 2023
- On Track for Updates on pheEDIT and juMPStart Programs by End of 2022 - - Prioritized Pipeline, Shifting Resources to HMI-103 PKU Gene Editing Trial in.
Homology Medicines Reports Second Quarter 2022 Financial Results, Recent Highlights and Provides Business Update streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
HIV Vaccine and Cure News: The Real Story Behind the Recent Hype thebody.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thebody.com Daily Mail and Mail on Sunday newspapers.
- Formed New AAV Manufacturing and Innovation Business with Oxford Biomedica to Leverage Homology’s Process Development and Manufacturing Capabilities - - Received $130 Million Non-Dilutive. | March 23, 2022